Old Web
English
Sign In
Acemap
>
Paper
>
Correction to: Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience.
Correction to: Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience.
2021
Antonella Bruzzese
Giovanni Manfredi Assanto
Daniela Diverio
Luisa Quattrocchi
D. Carmini
Ursula La Rocca
Maria Stefania De Propris
Silvia Maria Trisolini
Mattia Brescini
Giulia Galassi
Walter Barberi
Anna Paola Iori
Keywords:
Sorafenib
Medicine
Single Center
Oncology
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]